z-logo
Premium
PROX1 overexpression inhibits protein kinase C beta II transcription through promoter DNA methylation
Author(s) -
Hagiwara Kazumi,
Ito Hiromi,
Murate Takashi,
Miyata Yasuhiko,
Ohashi Haruhiko,
Nagai Hirokazu
Publication year - 2012
Publication title -
genes, chromosomes and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.754
H-Index - 119
eISSN - 1098-2264
pISSN - 1045-2257
DOI - 10.1002/gcc.21985
Subject(s) - demethylating agent , dna methylation , microbiology and biotechnology , biology , cpg site , methylation , transcription (linguistics) , carcinogenesis , cell growth , hela , cell culture , gene , gene expression , genetics , linguistics , philosophy
Prospero‐related homeobox 1 ( PROX1 ) is important for embryonic organ formation and differentiation, and changes in PROX1 activity were recently associated with cancer. To address the PROX1 roles in tumorigenesis, we established cells stably overexpressing PROX1 using the human cervical cancer cell line, HeLa. Overexpression of PROX1 reduced cell proliferation and the rate of tumor formation as compared with controls. Comparison of gene expression profiles between PROX1‐overexpressing and mock‐transfected cells revealed that the expression of protein kinase C βII ( PRKCB2 ) is down‐regulated in PROX1‐overexpressing cells. A PRKCB inhibitor suppressed cell growth of control cells more than PROX1‐expressing cells. Analysis of the 5′‐promoter of PRKCB revealed that a region between −110 bp and the first exon contains two Sp1 binding sites and is important for transcriptional regulation of PRKCB . The inhibition of Sp1 transcription factor resulted in down‐regulation of PRKCB2 protein levels. Treatment with a demethylating agent, 5‐aza‐2′‐deoxycytidine, restored PRKCB2 mRNA expression in PROX1‐expressing cells, suggesting that the 5′‐promoter of PRKCB is methylated in these cells. Actually, it was found that a CpG island in this region, in particular a CpG site overlapping with the distal Sp1 site, was hypermethylated and direct Sp1 binding to this region was inhibited in PROX1‐overexpressing cells. Thus, the suppressive effect of PROX1 on cell growth and tumor formation might be partially mediated by PRKCB2 via altered methylation of its promoter. © 2012 Wiley Periodicals, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here